Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
NCT01305317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2011-03-01
Summary
This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas
Conditions
Interventions
- DRUG
-
Lipitor
Atorvastatin 20mg daily for 6 months
Sponsors & Collaborators
-
Hormozgan University of Medical Sciences
lead OTHER
Principal Investigators
-
Hamidreza Mahboobi · Hormozgan University of Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2008-01-31
- Completion
- 2010-01-31
Countries
- Iran
Study Locations
More Related Trials
-
Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
NCT00521508 ·Status: COMPLETED ·Phase: NA
-
Renal Manifestations of IBD
NCT04301297 ·Status: UNKNOWN
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure
NCT03220685 ·Status: COMPLETED
-
Dose Effect Relationship of MTX and IBD
NCT03531593 ·Status: COMPLETED
-
Biomarkers for the Progression of IgA Nephropathy
NCT02529722 ·Status: COMPLETED
-
An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
NCT01502579 ·Status: COMPLETED
-
PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
NCT05810480 ·Status: RECRUITING
-
Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
NCT00001351 ·Status: ENROLLING_BY_INVITATION
-
IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
NCT01775527 ·Status: COMPLETED ·Phase: NA
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Correlation of Microbiome and Metabonomics With IgA Nephropathy
NCT05190848 ·Status: RECRUITING
-
Fibroscan to Guide Post Transplant Immunosuppression Minimization
NCT07206277 ·Status: RECRUITING ·Phase: NA
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
NCT06350630 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
NCT00004305 ·Status: COMPLETED
-
Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms
NCT00015431 ·Status: COMPLETED
-
Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis
NCT01655121 ·Status: COMPLETED ·Phase: NA
-
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
NCT05473403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
NCT02954419 ·Status: RECRUITING
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
The Role of Immune Semaphorins in NAFLD
NCT04573543 ·Status: COMPLETED
-
Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease
NCT06655831 ·Status: NOT_YET_RECRUITING
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
NCT02493101 ·Status: COMPLETED